John Mark Lucas

John Mark Lucas is the founder of Axelyf, Inc. Former jobs include Chief Executive Officer at Cizzle Biotechnology Ltd., Chief Executive Officer & Executive Director at Oxford Cannabinoid Technologies Holdings Plc from 2021 to 2022, Director of New Product Development & IP at Venture Life Group Plc, Vice President-World Wide Intellectual Property at Serono Genetics Institute SA, Vice President-Intellectual Property at Metabasis Therapeutics, Inc., General Counsel at Silence Therapeutics Plc from 2009 to 2010, Vice President-Intellectual Property at TransForm Pharmaceuticals, Inc., Vice President-Worldwide Intellectual Property at Genset Corp., Head-Patents at Boehringer Ingelheim Pharma GmbH & Co., KG, and Vice President-Intellectual Property at Ilika Plc.
Education includes a graduate degree from George Washington University, a doctorate from The Ohio State University, and undergraduate and graduate degrees from The Ohio University.